期刊文献+

非小细胞肺癌脑转移的发生及预后多因素分析 被引量:10

Effects of Multiple Factors on Occurrence and Prognosis of Brain Metastases from Non-Small-Cell Lung Carcinoma
下载PDF
导出
摘要 目的探讨并分析各种临床、病理因素对非小细胞肺癌(NSCLC)脑转移的发生及其预后的影响。方法回顾性分析464例NSCLC患者(非脑转移399例,脑转移65例)的临床资料。生存期定义为患者确诊的时间至死亡或随访结束的时间。应用Kaplan-Meier方法计算患者确诊为肺癌脑转移后的1、2、3年生存率和中位生存期并描绘生存曲线,采用Logistic回归分析肺癌脑转移发生的高危因素,采用Cox模型对肺癌脑转移患者的预后进行多因素分析,并进行Log-rank时序检验。结果 Logistic回归显示,TNM分期、治疗前CEA水平、有无其他远处转移和是否放疗为NSCLC脑转移发生的主要影响因素。Cox回归多因素分析表明,是否手术和颅内转移数是NSCLC脑转移患者的独立预后因素。结论 TNM分期较晚、治疗前CEA水平较高、存在其他远处转移和未经放疗的NSCLC患者发生脑转移的概率较高,单发脑转移的患者和经手术治疗的患者生存期较长。 Objective To investigate and analyze the effects of various clinicopathologic factors on the occurrence and prognosis of brain metastases from non-small-cell lung carcinoma (NSCLC). Methods Clinical data of 399 NSCLC patients without brain metastases and 65 NSCLC patients with brain metastases were retrospectively analyzed. Survival time was defined as the time from diagnosis to death or end of follow-up. Kaplan-Meier method was used to calculate the 1-,2-,and 3-year survival rates and median survival time. Logistic regression and Cox model were used to analyze the risk factors and prognostic factors for brain metastases from NSCLC, re spectively. In addition, the comparison was performed using log-rank test. Results Logistic re gression analysis showed that TNM staging,CEA levels before treatment,distant metastases and radiotherapy were the major factors influencing brain metastases from NSCLC. Cox multivariate analysis showed that the operation and number of intracranial metastases were the independent prognostic factors for brain metastases from NSCLC. Conclusion Advanced TNM staging,high CEA levels before treatment, distant metastases, and treatment without radiotherapy were posi tively associated with the occurrence of brain metastases in NSCLC patients. However, patients with single brain metastasis and patients undergoing operation have longer survival time.
出处 《南昌大学学报(医学版)》 CAS 2013年第12期43-46,共4页 Journal of Nanchang University:Medical Sciences
关键词 非小细胞肺癌 脑转移 预后因素 影响因素 non-small-cell lung carcinoma brain metastases prognostic factors influence factors
  • 相关文献

参考文献13

  • 1Ferlay J,Shin H R,Bray F. Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J].{H}International Journal of Cancer,2010,(12):2893-2917.
  • 2Jemal A,Siegel R,Ward E. Cancer statistics,2007[J].CA Cancer J Clin,2007,(1):43-66.
  • 3Hoang T,Xu R,Schiller J H. Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data[J].{H}Journal of Clinical Oncology,2005,(1):175-183.
  • 4Mandrekar S J,Schild S E,Hillman S L. A prognostic model for advanced stage nonsmall cell lung cancer.Pooled analysis of North Central Cancer Treatment Group trials[J].{H}CANCER,2006,(4):781-792.
  • 5梁颖,林勇斌,张力,王思愚,吴海鹰,陈丽昆,李明毅,徐光川,戒铁华,何友兼.ⅢA期非小细胞肺癌患者术后脑转移高危临床因素分析[J].中国肿瘤临床,2010,37(21):1232-1236. 被引量:6
  • 6P(o)ttgen C,Eberhardt W,Grannass A. Prophylactic cranial irradiation in operable stage ⅢA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy:results from a German multicenter randomized trial[J].{H}Journal of Clinical Oncology,2007,(31):4987-4992.
  • 7Sajama C,Lorenzoni J,Tagle P. Diagnosis and treatment of brain metastasi[J].{H}Revista Medica de Chile,2008,(10):1321-1326.
  • 8Maemondo M,Inoue A,Kobayashi K. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR[J].{H}New England Journal of Medicine,2010,(2):2380-2388.
  • 9朱世杰,马翠芹,许轶琛,贾立群,李佩文.41例非小细胞肺癌脑转移生存分析[J].中日友好医院学报,2008,22(6):334-336. 被引量:4
  • 10No authors listed. Chemotherapy in non-small cell lung cancer:a meta-analysis using updated data on individual patients from 52 randomised clinical trials.Non-small Cell Lung Cancer Collaborative Group[J].{H}BMJ:British Medical Journal,1995,(7010):899-909.

二级参考文献20

  • 1许亚萍,马胜林.非小细胞肺癌脑转移治疗现状[J].中国肺癌杂志,2007,10(3):259-262. 被引量:16
  • 2王伟,李辉,尚立群,李学昌,李军,宋伟安,文峰.32例肺癌脑转移综合治疗疗效分析[J].中华胸心血管外科杂志,2006,22(3):168-168. 被引量:4
  • 3叶雄,王思愚,区伟,曾智帆,林勇斌,张彬彬.局部晚期非小细胞肺癌术后脑转移高危因素分析[J].中国肺癌杂志,2007,10(2):111-115. 被引量:10
  • 4贺铭言,尤庆山,常金.89例肺癌脑转移病例放疗疗效分析[J].实用肿瘤学杂志,2007,21(3):238-243. 被引量:11
  • 5Kim DY,Lee KW,Yun T,et al.Efficaey of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer [J].Oncol Rep, 2005,14(1) : 207-211.
  • 6Kong DS,Lee JI,Nam DH,et al.Prognosis of non-small cell lung cancer with synchronous brain metastases treated with gamma knife radiosurgery [J].J Korean Med Sci,2006,21(3): 527-532.
  • 7Hall WA,Djalilian HR,Nussbaum ES,et al.Long-term survival with metastatic cancer to the brain [J].Med Oncol, 2000,17(4) : 279-286.
  • 8Noordijk EM,Vecht CJ,Haaxma-Reiche H,et al.The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age [J].Int J Radiat Oncol Biol Phys, 1994,29(4) : 711-717.
  • 9Cortes J,Rodriguez J,Aramendia JM,et al.Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer[J].Oncology,2003,64(1):28-35.
  • 10Fujita A,Fukuoka S,Takabatake H,et al.Combination chemotherapy of cisplatin,ifosfamide,and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer[J].Oneology,2000,59(4):291-295.

共引文献8

同被引文献86

  • 1章卫华,叶敏,周荣伟,孙坚.完整切除ⅢA期非小细胞肺癌术后脑转移的临床特征及危险因素分析[J].中国老年学杂志,2014,34(1):107-108. 被引量:5
  • 2沈四新,方鹏,江晓肖,钱伟,毛树权,吴彩珍.228例肺癌脑转移综合治疗临床分析[J].临床肺科杂志,2005,10(5):622-623. 被引量:4
  • 3叶雄,王思愚,区伟,曾智帆,林勇斌,张彬彬.局部晚期非小细胞肺癌术后脑转移高危因素分析[J].中国肺癌杂志,2007,10(2):111-115. 被引量:10
  • 4郝捷,陈万青(主编).中国肿瘤登记年报(2012)[M].北京:军事医学科学出版社,2012.12-30.
  • 5Kaduthanam S,Gade S,Meister M,et al. Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients[J]. Lung Cancer,2013,80(2):223-227.
  • 6Lee S M,Park J Y,Kim D S. Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer[J]. Mol Cel:s,2012,34(2) :171-176.
  • 7Thunnissen E, Boers E, Heideman D A, et al. Correlation of immunohistoehemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma[J]. Virchows Arch, 2012,461 (6):629 -638.
  • 8Travis W D,Colby T V, Corrin B, et al. Histological typing of lung and pleural tumours[M]//World Health Organization. International histological classification of tumors. 3th ed. Berlin: Springer-Verlag, 1999 : 28-35.
  • 9Sobin L H, Wittekind C H. TNM classification of malignant tumours[M].6th ed. New York : Wiley-Liss, 2002 : 2.
  • 10Bouzas P R,Aguilera A M,Ruiz Fuentes N. Functional estimation of the random rate of a Cox process[M]. Methodol Corn put Appl Prohab,2010,14(1) :57-69.

引证文献10

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部